Internal Medicine

3151 questions

Question 1521Question →

During morning rounds, the healthcare team reviews the laboratory results of a 58-year-old woman admitted to the intensive care unit three days ago for severe community-acquired pneumonia and sepsis. Her respiratory status has significantly improved following the administration of appropriate intravenous antibiotics and supportive care. Vital signs today show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 118/76 mm Hg118/76\text{ mm Hg}, heart rate of 88/min88\text{/min}, and respiratory rate of 16/min16\text{/min}. As part of a broad laboratory panel ordered on admission, her thyroid studies return with the following values:

Thyroid-stimulating hormone (TSH): 0.3 μU/mL0.3\text{ }\mu\text{U/mL} (Normal: 0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL})
Free T4: 0.7 ng/dL0.7\text{ ng/dL} (Normal: 0.9−2.4 ng/dL0.9-2.4\text{ ng/dL})
Total T3: 45 ng/dL45\text{ ng/dL} (Normal: 80−200 ng/dL80-200\text{ ng/dL})

The patient has no history of thyroid disease and takes no home medications. Physical examination reveals a normal-sized thyroid gland without nodules, normal deep tendon reflexes, and no tremors. Which of the following is the most appropriate next step in the management of this patient's thyroid laboratory findings?

Show answer & explanation

Answer: Reassurance and repeat thyroid studies in 6 to 8 weeks

Answer

Reassurance and repeat thyroid studies in 6 to 8 weeks
This patient's clinical presentation and laboratory findings are highly characteristic of nonthyroidal illness syndrome (often referred to as euthyroid sick syndrome). This condition frequently occurs in patients with severe acute illnesses, such as sepsis, trauma, or major surgery. The pathogenesis involves decreased peripheral conversion of T4 to active T3, increased conversion to reverse T3, and transient central suppression of the hypothalamic-pituitary-thyroid axis. Early in the illness, this presents primarily as a low total T3 level (referred to as "low T3 syndrome"). As the illness becomes more severe or prolonged, TSH and free T4 levels also decline. Because this is a physiologic adaptation to severe physiological stress rather than a true thyroid gland dysfunction, thyroid hormone replacement (e.g., levothyroxine) is not beneficial and is generally not recommended. The most appropriate management is reassurance, treatment of the underlying condition, and repeating thyroid function tests in 6 to 8 weeks after the patient has fully recovered from the acute illness.

Step-by-Step Solution

1
Analyze the patient's clinical context.
The patient is hospitalized in the ICU for a severe acute illness (pneumonia and sepsis) but is currently clinically improving and hemodynamically stable.
Establishing the clinical state differentiates chronic endocrine pathologies from acute physiologic adaptations to stress.
2
Interpret the thyroid function tests.
The tests show decreased total T3, decreased free T4, and mildly decreased TSH.
Identifying the specific pattern of hormone alterations helps pinpoint the etiology of the derangement.
3
Synthesize the clinical and laboratory data to form a diagnosis.
The combination of severe acute illness with low T3, low T4, and low/normal TSH indicates nonthyroidal illness syndrome (euthyroid sick syndrome).
Severe physiological stress leads to decreased peripheral conversion of T4 to T3 and transient central suppression of TSH release.
4
Determine the most appropriate management.
Observation and deferring repeat testing until weeks after hospital discharge is recommended.
Exogenous thyroid hormone does not improve outcomes in nonthyroidal illness syndrome, and values typically normalize once the underlying acute illness resolves.

Key Concept

Diagnosis and management of nonthyroidal illness syndrome (euthyroid sick syndrome)
Estimated Time:1m 15s
Question 1522Question →

A 5454-year-old woman is evaluated in the emergency department for a fever that started 66 hours ago. She is currently hospitalized and undergoing induction chemotherapy for acute myeloid leukemia (AML). She reports mild generalized fatigue but denies cough, shortness of breath, dysuria, abdominal pain, or diarrhea. Her temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), blood pressure is 112/72 mm Hg112/72 \text{ mm Hg}, pulse is 108/min108/\text{min}, and respiratory rate is 16/min16/\text{min}. Physical examination reveals a clean and intact right internal jugular central venous catheter site with no surrounding erythema, induration, or tenderness. The lungs are clear to auscultation bilaterally. There are no oral ulcers or skin rashes.

Laboratory studies show:

ParameterResult
Hemoglobin8.4 g/dL8.4 \text{ g/dL}
Platelets42,000/mm342,000/\text{mm}^3
Leukocytes800/mm3800/\text{mm}^3
Neutrophils10%10\%
Lymphocytes85%85\%
Eosinophils2%2\%
Monocytes3%3\%
Serum creatinine0.9 mg/dL0.9 \text{ mg/dL}

Blood and urine cultures have been obtained. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravenous cefepime

Answer

Intravenous cefepime
The correct answer is intravenous cefepime. This patient presents with a fever (38.6∘C38.6^\circ\text{C}) and an absolute neutrophil count (ANC) of 80/mm380/\text{mm}^3, meeting the diagnostic criteria for neutropenic fever. Patients with an ANC <500/mm3< 500/\text{mm}^3 have an impaired inflammatory response, meaning a fever may be the only sign of a life-threatening infection. Because the risk of rapid progression to septic shock (particularly from Pseudomonas aeruginosa and other Gram-negative bacilli) is extremely high, empiric broad-spectrum antibiotic therapy must be initiated immediately after blood and urine cultures are obtained. High-risk patients—such as those with hematologic malignancies, anticipated prolonged neutropenia (>7> 7 days), or profound neutropenia (ANC ≤100/mm3\leq 100/\text{mm}^3)—require hospitalization and intravenous therapy with an anti-pseudomonal beta-lactam, such as cefepime, meropenem, or piperacillin-tazobactam.

Step-by-Step Solution

1
Calculate the Absolute Neutrophil Count (ANC).
ANC=Total Leukocytes×(%Neutrophils+%Bands)\text{ANC} = \text{Total Leukocytes} \times (\% \text{Neutrophils} + \% \text{Bands}). For this patient, ANC=800×0.10=80/mm3\text{ANC} = 800 \times 0.10 = 80/\text{mm}^3.
ANC determines the severity of immunosuppression and risk for life-threatening bacterial infections.
2
Identify the clinical syndrome based on vital signs and lab results.
The patient has a fever (38.6∘C38.6^\circ\text{C}) accompanied by an ANC <500/mm3< 500/\text{mm}^3, confirming the diagnosis of neutropenic fever.
Neutropenic fever is an oncologic emergency requiring immediate recognition to prevent rapid clinical deterioration.
3
Risk-stratify the patient to determine the appropriate route and spectrum of antimicrobial therapy.
The patient is undergoing induction chemotherapy for acute myeloid leukemia (AML), placing her at high risk for prolonged, profound neutropenia and severe infections.
High-risk patients require inpatient intravenous therapy, whereas low-risk patients (e.g., solid tumors, stable vitals) may be managed with oral antibiotics.
4
Select the optimal empiric antimicrobial regimen.
Immediate administration of an empiric intravenous anti-pseudomonal beta-lactam, such as cefepime, meropenem, or piperacillin-tazobactam, is indicated.
Gram-negative bacteremia (particularly Pseudomonas aeruginosa) can cause rapid, fatal septic shock in neutropenic patients without prompt broad-spectrum coverage.

Key Concept

Neutropenic fever (temperature ≥38.3∘C\geq 38.3^\circ\text{C} and ANC <500/mm3< 500/\text{mm}^3) in high-risk patients requires immediate empiric therapy with an intravenous anti-pseudomonal beta-lactam (e.g., cefepime, meropenem, or piperacillin-tazobactam) to prevent rapid progression to septic shock.
Question 1523Question →

Following an emergency exploratory laparotomy for ischemic colitis, a 6868-year-old patient remains mechanically ventilated in the surgical intensive care unit. Over the past 4848 hours, continuous nasogastric suctioning has yielded 2.52.5 liters of fluid. The patient is currently receiving continuous intravenous infusions of fentanyl and propofol. Current vital signs include a temperature of 38.9∘C38.9^\circ C (102.0∘F102.0^\circ F), pulse of 118118/min, and blood pressure of 88/5488/54 mm Hg. The ventilator is set to synchronized intermittent mandatory ventilation mode, and the patient is triggering very few spontaneous breaths.

Laboratory evaluation demonstrates:

ParameterValue
Arterial pHpH7.237.23
Arterial pCO2pCO_25050 mm Hg
Arterial pO2pO_27272 mm Hg
Serum Na+Na^+140140 mEq/L
Serum K+K^+3.13.1 mEq/L
Serum Cl−Cl^-8888 mEq/L
Serum HCO3−HCO_3^-2020 mEq/L
Blood Urea Nitrogen4242 mg/dL
Serum Creatinine2.52.5 mg/dL
Serum Lactate5.85.8 mmol/L

What is the complete characterization of this patient's acid-base status?

Show answer & explanation

Answer: High anion gap metabolic acidosis, metabolic alkalosis, and respiratory acidosis

Answer

The patient has a triple acid-base disorder consisting of a high anion gap metabolic acidosis, a metabolic alkalosis, and a respiratory acidosis.
The correct answer identifies all three components of the patient's complex acid-base disturbance. The patient has acidemia (pH<7.35pH < 7.35). Step 1: The anion gap is 3232 (140−(88+20)140 - (88 + 20)), indicating a high anion gap metabolic acidosis. Step 2: The delta gap is 2020 (32−1232 - 12). The expected bicarbonate is 44 mEq/L (24−2024 - 20), but the measured bicarbonate is 2020 mEq/L. This gap indicates a concurrent metabolic alkalosis. Step 3: Winter's formula predicts an expected pCO2pCO_2 of 38±238 \pm 2 mm Hg (1.5×20+81.5 \times 20 + 8). The actual pCO2pCO_2 is 5050 mm Hg, which is higher than expected, confirming an additional respiratory acidosis.

Step-by-Step Solution

1
Calculate the anion gap to identify the primary metabolic disturbance.
AG=Na+−(Cl−+HCO3−)=140−(88+20)=32AG = Na^+ - (Cl^- + HCO_3^-) = 140 - (88 + 20) = 32 mEq/L.
An elevated anion gap (>12>12 mEq/L) indicates a primary high anion gap metabolic acidosis (HAGMA), which in this hypotensive patient is secondary to lactic acidosis and uremia.
2
Calculate the delta-delta gap to evaluate for concurrent metabolic disorders.
ΔAG=32−12=20\Delta AG = 32 - 12 = 20 mEq/L. Expected HCO3−=24−20=4HCO_3^- = 24 - 20 = 4 mEq/L. The actual HCO3−HCO_3^- is 2020 mEq/L.
Because the actual HCO3−HCO_3^- (2020 mEq/L) is significantly higher than the expected HCO3−HCO_3^- (44 mEq/L), there must be a concurrent process adding bicarbonate. This indicates a superimposed metabolic alkalosis, driven by the continuous nasogastric suctioning (loss of H+H^+ and Cl−Cl^-).
3
Use Winter's formula to determine if respiratory compensation is appropriate.
Expected pCO2=(1.5×20)+8±2=38±2pCO_2 = (1.5 \times 20) + 8 \pm 2 = 38 \pm 2 mm Hg. The actual pCO2pCO_2 is 5050 mm Hg.
Because the actual pCO2pCO_2 (5050 mm Hg) is greater than the expected range (36−4036-40 mm Hg), the patient is hypoventilating relative to their metabolic state. This indicates a concurrent respiratory acidosis, secondary to heavy sedation and the set ventilator mode.

Key Concept

A triple acid-base disorder can be correctly diagnosed by sequentially evaluating the arterial pH, calculating the anion gap, utilizing the delta-delta calculation, and applying Winter's formula to assess respiratory compensation.
Estimated Time:2m 30s
Question 1524Question →

Match each patient's clinical presentation with the classic renal biopsy finding most likely to be seen in their condition.

Click a left item, then click its matching right item

Items

A 32-year-old woman with systemic lupus erythematosus presents with hypertension, erythrocyte casts, and a rising serum creatinine.
A 48-year-old man with chronic hepatitis C and mixed cryoglobulinemia develops new-onset hematuria and proteinuria.
A 55-year-old man with untreated HIV infection presents with severe generalized edema and 8 g/day of proteinuria.
A 60-year-old man with recently diagnosed colon cancer presents with anasarca, normal renal function, and heavy proteinuria.
A 22-year-old man with a family history of renal failure presents with microscopic hematuria, sensorineural deafness, and anterior lenticonus.

Matches

Show answer & explanation

Answer

DPGN corresponds to wire loops; MPGN corresponds to tram-track appearance; FSGS corresponds to segmental sclerosis; Membranous nephropathy corresponds to spike and dome pattern; Alport syndrome corresponds to basket-weave appearance.
Each vignette represents a classic systemic trigger for a specific glomerular disease. By recognizing the associations (SLE with DPGN, HCV with MPGN, HIV with FSGS, solid tumor with Membranous Nephropathy, and type IV collagen defect with Alport syndrome), one can definitively pair the clinical presentation with its pathognomonic microscopic description.

Step-by-Step Solution

1
Analyze the SLE vignette (left_1).
Identifies Diffuse Proliferative Glomerulonephritis (DPGN).
SLE with nephritic syndrome and active urinary sediment points to DPGN, which matches with 'wire loop' subendothelial deposits.
2
Analyze the Hepatitis C and cryoglobulinemia vignette (left_2).
Identifies Membranoproliferative Glomerulonephritis (MPGN) Type 1.
Chronic HCV and cryoglobulinemia are strong triggers for MPGN, matching with mesangial interposition and the 'tram-track' appearance.
3
Analyze the HIV infection vignette (left_3).
Identifies Focal Segmental Glomerulosclerosis (FSGS).
Uncontrolled HIV is classically associated with the collapsing variant of FSGS, which presents with massive proteinuria and segmental sclerosis.
4
Analyze the colon cancer vignette (left_4).
Identifies Membranous Nephropathy.
Solid organ malignancies can precipitate secondary Membranous Nephropathy, matching the subepithelial 'spike and dome' appearance.
5
Analyze the familial deafness and lenticonus vignette (left_5).
Identifies Alport Syndrome.
The clinical triad is pathognomonic for Alport syndrome, caused by a type IV collagen defect, matching the 'basket-weave' GBM finding.

Key Concept

Correlation of systemic diseases with secondary glomerular pathologies and their classic microscopic findings.
Estimated Time:2m 0s
Question 1525Question →

A 5454-year-old woman is evaluated in the intensive care unit on day 1414 of an admission for severe acute respiratory distress syndrome (ARDS) secondary to viral pneumonia. She was treated with a 1010-day course of intravenous dexamethasone, which was completed two days ago. The patient remains on mechanical ventilation, but her oxygen requirements are slowly decreasing. While attempting to wean sedation, the patient appears profoundly lethargic and unresponsive to verbal stimuli. Her temperature is 36.2∘C36.2^\circ\text{C} (97.2∘F97.2^\circ\text{F}), pulse is 92/min92/\text{min}, and blood pressure is 110/68 mmHg110/68\text{ mmHg}. Physical examination reveals trace bilateral pedal edema and delayed relaxation of deep tendon reflexes. A thyroid panel is obtained to evaluate her delayed awakening:

Laboratory ParameterValueReference Range
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2\text{ }\mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL}
Free thyroxine (T4)0.7 ng/dL0.7\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}
Total triiodothyronine (T3)42 ng/dL42\text{ ng/dL}80−200 ng/dL80-200\text{ ng/dL}

Based on these findings, which of the following is the most appropriate next step in the management of this patient's thyroid function?

Show answer & explanation

Answer: Observation without thyroid hormone supplementation

Answer

Observation without thyroid hormone supplementation
The correct option proposes observation without supplementation. This patient's clinical presentation (delayed awakening, hypothermia, edema, delayed reflexes) and laboratory profile (low T3, low T4, low TSH) in the setting of an extended ICU stay is classic for euthyroid sick syndrome (also known as nonthyroidal illness syndrome). Early in critical illness, decreased peripheral conversion of T4 to T3 results in isolated low T3 (often with elevated reverse T3). In prolonged critical illness, as seen in this patient on day 14, central suppression occurs, leading to drops in TSH and free T4. This central suppression was likely further exacerbated by her recent course of high-dose dexamethasone. Because these changes represent a physiologic, energy-conserving adaptation to severe stress rather than true hypothyroidism, exogenous thyroid hormone administration is not indicated. It does not improve survival or time to extubation and is therefore managed with observation and repeat testing upon clinical recovery.

Step-by-Step Solution

1
Analyze the laboratory profile in the context of the patient's presentation.
The patient has low total T3, mildly low free T4, and mildly low TSH in the setting of prolonged critical illness (ICU day 14) and recent high-dose dexamethasone use.
Accurate interpretation of thyroid function tests requires integrating the clinical scenario, as severe physiologic stress profoundly alters the hypothalamic-pituitary-thyroid axis.
2
Identify the underlying pathophysiology causing these laboratory abnormalities.
The findings are diagnostic of euthyroid sick syndrome (nonthyroidal illness syndrome). Furthermore, exogenous glucocorticoids directly suppress TSH secretion.
Severe illness decreases peripheral 5′5'-deiodination (diverting T4 to inactive reverse T3 instead of active T3) and causes central suppression of TRH and TSH to conserve energy.
3
Determine the optimal management strategy for this condition.
The standard of care is observation and re-evaluation after clinical recovery.
Clinical trials demonstrate that thyroid hormone replacement in euthyroid sick syndrome provides no clinical benefit and may potentially worsen catabolism and clinical outcomes.

Key Concept

Euthyroid sick syndrome (nonthyroidal illness syndrome)

Alternative Method

When evaluating an abnormal thyroid panel in the ICU, immediately check the patient's medication list for drugs that suppress TSH (e.g., glucocorticoids, dopamine, octreotide) or alter binding globulins, which can mimic or exacerbate the laboratory appearance of euthyroid sick syndrome.
Estimated Time:1m 30s
Question 1526Question →

Review the four distinct patient laboratory profiles concerning calcium and bone metabolism. Reference ranges: Calcium 8.4-10.2 mg/dL; Phosphorus 2.5-4.5 mg/dL; Intact PTH 15-65 pg/mL; 25-hydroxyvitamin D 20-50 ng/mL; 1,25-dihydroxyvitamin D 18-72 pg/mL. Assign each laboratory profile to the most accurate underlying pathophysiologic etiology.

Click a left item, then click its matching right item

Items

Profile 1: Calcium 11.2 mg/dL, phosphorus 2.4 mg/dL, intact PTH 10 pg/mL, 1,25-dihydroxyvitamin D 12 pg/mL
Profile 2: Calcium 11.6 mg/dL, phosphorus 2.2 mg/dL, intact PTH 125 pg/mL, urine calcium-to-creatinine clearance ratio (UCCR) 0.035
Profile 3: Calcium 11.1 mg/dL, phosphorus 3.2 mg/dL, intact PTH 58 pg/mL, urine calcium-to-creatinine clearance ratio (UCCR) 0.006
Profile 4: Calcium 8.1 mg/dL, phosphorus 2.1 mg/dL, intact PTH 155 pg/mL, 25-hydroxyvitamin D 9 ng/mL

Matches

Show answer & explanation

Answer

Profile 1 correlates with Humoral hypercalcemia of malignancy; Profile 2 correlates with Primary hyperparathyroidism; Profile 3 correlates with Familial hypocalciuric hypercalcemia; Profile 4 correlates with Severe vitamin D deficiency.
The calcium-PTH axis must be interpreted stepwise. High calcium with suppressed PTH implies a non-parathyroid source (e.g., PTHrP in malignancy). High calcium with normal/elevated PTH indicates a parathyroid-dependent source, requiring UCCR to distinguish primary hyperparathyroidism from FHH. Low calcium with low phosphorus implies vitamin D deficiency, as PTH is elevated but cannot compensate without sufficient vitamin D substrate.

Step-by-Step Solution

1
Evaluate Profile 1's PTH level in the context of hypercalcemia.
PTH is appropriately suppressed (10 pg/mL).
This rules out PTH-dependent causes. The low 1,25-dihydroxyvitamin D further differentiates PTHrP-mediated hypercalcemia from extrarenal calcitriol production (e.g., sarcoidosis).
2
Analyze Profile 2 and Profile 3, which both feature hypercalcemia with unsuppressed PTH.
Profile 2 has a UCCR > 0.02, while Profile 3 has a UCCR < 0.01.
UCCR is essential to differentiate primary hyperparathyroidism (high relative urine calcium clearance) from FHH (impaired renal calcium sensing leading to hypocalciuria).
3
Assess Profile 4's calcium and phosphorus levels.
Both are low, accompanied by an elevated PTH and low 25-hydroxyvitamin D.
Low vitamin D leads to decreased intestinal calcium and phosphorus absorption, triggering a secondary rise in PTH, which further lowers phosphorus via phosphaturia.

Key Concept

Differentiation of hypercalcemic and hypocalcemic disorders using intact PTH, phosphorus, 1,25-dihydroxyvitamin D, and urine calcium-to-creatinine clearance ratio.
Estimated Time:1m 30s
Question 1527Question →

Match each clinical vignette describing a patient's presentation to the autoantibody profile most closely associated with their underlying condition.

Click a left item, then click its matching right item

Items

A 52-year-old woman with a history of recurrent dental caries presents with a 6-month history of foreign body sensation in her eyes and recent bilateral swelling of the preauricular area.
A 34-year-old woman presents with a 3-month history of swollen fingers, episodic color changes in her hands upon cold exposure, and recent difficulty rising from a chair.
A 48-year-old man develops progressive difficulty climbing stairs over 2 months, accompanied by an erythematous rash on his upper eyelids and scaling plaques on his knuckles.
A 42-year-old woman presents with rapidly progressive skin tightening extending proximal to her elbows over 4 months, gastroesophageal reflux, and new-onset exertional dyspnea.

Matches

Show answer & explanation

Answer

The Sjögren syndrome vignette matches with Anti-Ro/SSA and Anti-La/SSB antibodies; the mixed connective tissue disease vignette matches with Anti-U1 RNP antibodies; the dermatomyositis vignette matches with Anti-Jo-1 antibodies; the diffuse cutaneous systemic sclerosis vignette matches with Anti-Scl-70 antibodies.
Each clinical vignette provides classic pathognomonic features of a distinct rheumatologic condition, which corresponds to a highly specific serologic marker. Sjögren syndrome is characterized by sicca symptoms and Anti-Ro/La antibodies. Mixed connective tissue disease presents with overlapping features and requires Anti-U1 RNP antibodies for diagnosis. Dermatomyositis presents with characteristic rashes and muscle weakness, and is frequently associated with Anti-Jo-1 antibodies. Diffuse cutaneous systemic sclerosis involves widespread skin thickening and internal organ fibrosis, which is linked to Anti-Scl-70 antibodies.

Step-by-Step Solution

1
Analyze the first clinical vignette to identify the underlying diagnosis.
Sjögren syndrome is identified.
The patient has classic sicca symptoms (dry eyes, dental caries from dry mouth) and parotid gland enlargement.
2
Identify the primary autoantibody profile for Sjögren syndrome.
Anti-Ro/SSA and Anti-La/SSB antibodies.
These are the most specific serologic markers associated with this condition.
3
Evaluate the second vignette for diagnostic features.
Mixed connective tissue disease is diagnosed.
The patient presents with overlapping symptoms from multiple connective tissue diseases (sclerosis, myositis, Raynaud phenomenon).
4
Identify the essential serologic marker for mixed connective tissue disease.
Anti-U1 RNP antibodies.
High titers of these antibodies are required for the diagnosis of MCTD.
5
Analyze the third vignette.
Dermatomyositis is identified.
The presentation of progressive proximal muscle weakness combined with a heliotrope rash and Gottron papules is classic.
6
Identify the common myositis-specific antibody for this condition.
Anti-Jo-1 antibodies.
This is a key antibody in dermatomyositis, especially when associated with anti-synthetase syndrome features.
7
Examine the fourth vignette.
Diffuse cutaneous systemic sclerosis is identified.
The patient has widespread skin thickening proximal to the elbows and visceral organ involvement (interstitial lung disease, gastroesophageal reflux).
8
Identify the autoantibody specific to diffuse systemic sclerosis.
Anti-Scl-70 antibodies.
This antibody is a specific marker for the diffuse subtype of scleroderma, contrasting with anti-centromere antibodies seen in the limited subtype.

Key Concept

Autoantibody profiles and classic clinical presentations in systemic rheumatologic diseases.
Question 1528Question →

Systemic vasculitides often present with a wide spectrum of overlapping clinical manifestations, but specific patterns of organ involvement, histological features, and autoantibody associations can help differentiate them. Match each of the following vasculitis diagnoses with its classic clinical presentation and associated laboratory findings.

Click a left item, then click its matching right item

Items

Granulomatosis with polyangiitis (GPA)
Eosinophilic granulomatosis with polyangiitis (EGPA)
Microscopic polyangiitis (MPA)
Polyarteritis nodosa (PAN)
IgA vasculitis

Matches

Show answer & explanation

Answer

Granulomatosis with polyangiitis (GPA) matches with upper respiratory tract involvement, lower respiratory tract nodules, and PR3-ANCA. Eosinophilic granulomatosis with polyangiitis (EGPA) matches with asthma, eosinophilia, and MPO-ANCA. Microscopic polyangiitis (MPA) matches with pulmonary capillaritis and glomerulonephritis without granulomas, associated with MPO-ANCA. Polyarteritis nodosa (PAN) matches with medium vessel inflammation sparing the lungs, associated with Hepatitis B. IgA vasculitis matches with palpable purpura, arthralgias, and abdominal pain.
Each vasculitis has a distinct clinical and pathophysiological profile that allows for specific identification based on organ involvement, histological presence of granulomas, and specific autoantibodies (such as PR3-ANCA and MPO-ANCA).

Step-by-Step Solution

1
Identify the key clinical features and serological markers for Granulomatosis with polyangiitis.
Matches with upper airway disease, lung nodules, glomerulonephritis, and PR3-ANCA.
GPA is defined by this classic clinical triad and its strong association with PR3-ANCA.
2
Identify the unique features of Eosinophilic granulomatosis with polyangiitis.
Matches with asthma, allergic rhinosinusitis, peripheral neuropathy, and eosinophilia.
The presence of asthma and significant eosinophilia are the defining features of EGPA among the ANCA-associated vasculitides.
3
Differentiate Microscopic polyangiitis from GPA.
Matches with necrotizing glomerulonephritis and pulmonary capillaritis, but lacks granulomas and upper airway disease, associated with MPO-ANCA.
MPA causes pulmonary-renal syndrome similar to GPA but is histologically distinct (no granulomas) and typically MPO-ANCA positive.
4
Identify the characteristic features of Polyarteritis nodosa.
Matches with segmental inflammation of medium arteries sparing the lungs, associated with hepatitis B.
Lung sparing and a strong association with hepatitis B virus are classic high-yield identifiers for PAN.
5
Identify the classic presentation of IgA vasculitis.
Matches with palpable purpura, arthralgias, and abdominal pain.
This is the classic tetrad of symptoms resulting from IgA immune complex deposition in small vessels.

Key Concept

Clinical and serological differentiation of systemic vasculitides.
Question 1529Question →

A 68-year-old man with a history of type 2 diabetes mellitus is brought to the emergency department due to progressively worsening confusion and profound weakness over the past 4 days. He recently recovered from a mild upper respiratory illness. On examination, he is lethargic but arousable. Vital signs show a blood pressure of 92/58 mm Hg92/58\text{ mm Hg}, a heart rate of 118/min118/\text{min}, and a respiratory rate of 16/min16/\text{min}. His mucous membranes are parched, and skin turgor is significantly decreased.

Initial laboratory evaluation reveals:
Serum sodium: 129 mEq/L129\text{ mEq/L}
Serum potassium: 4.4 mEq/L4.4\text{ mEq/L}
Serum chloride: 95 mEq/L95\text{ mEq/L}
Serum bicarbonate: 22 mEq/L22\text{ mEq/L}
Blood urea nitrogen: 48 mg/dL48\text{ mg/dL}
Serum creatinine: 1.9 mg/dL1.9\text{ mg/dL}
Serum glucose: 600 mg/dL600\text{ mg/dL}

In order to properly select the composition of intravenous fluids for resuscitation, the patient's true sodium status must be evaluated.

What is the patient's corrected serum sodium concentration in mEq/L\text{mEq/L}? (Assume a correction factor of 1.6 mEq/L1.6\text{ mEq/L} for each 100 mg/dL100\text{ mg/dL} increase in glucose above 100 mg/dL100\text{ mg/dL}).

Show answer & explanation

Answer: 137

Answer

137
In the setting of severe hyperglycemia, the high concentration of glucose in the extracellular fluid creates an osmotic gradient that draws water out of cells. This transcellular fluid shift dilutes the serum sodium concentration, leading to a phenomenon known as translocational hyponatremia. To determine the patient's true sodium status, a correction factor must be applied. The standard correction adds 1.6 mEq/L1.6\text{ mEq/L} to the measured sodium for every 100 mg/dL100\text{ mg/dL} increase in glucose above a baseline of 100 mg/dL100\text{ mg/dL}. For a glucose level of 600 mg/dL600\text{ mg/dL}, the excess is 500 mg/dL500\text{ mg/dL}. Multiplying 55 by 1.61.6 yields a correction of 8 mEq/L8\text{ mEq/L}. Adding this to the measured sodium of 129 mEq/L129\text{ mEq/L} results in a corrected serum sodium of 137 mEq/L137\text{ mEq/L}. This indicates that the patient actually has a normal serum sodium concentration, which is critical for choosing the appropriate intravenous fluid for resuscitation.

Step-by-Step Solution

1
Identify the patient's measured serum sodium and serum glucose levels.
Measured Na = 129 mEq/L129\text{ mEq/L}, Glucose = 600 mg/dL600\text{ mg/dL}.
These are the two variables required to calculate the corrected serum sodium.
2
Calculate the amount of glucose elevation above the normal baseline of 100 mg/dL100\text{ mg/dL}.
600−100=500 mg/dL600 - 100 = 500\text{ mg/dL} above normal.
The correction factor is only applied to the excess glucose driving the osmotic shift.
3
Determine the total sodium correction value by applying the given factor.
Correction = 5×1.6=8 mEq/L5 \times 1.6 = 8\text{ mEq/L}.
For every 100 mg/dL100\text{ mg/dL} of excess glucose, sodium is artificially lowered by 1.6 mEq/L1.6\text{ mEq/L}.
4
Add the correction value to the measured serum sodium.
129+8=137 mEq/L129 + 8 = 137\text{ mEq/L}.
This yields the true serum sodium concentration, guiding appropriate fluid therapy.

Key Concept

Pseudohyponatremia due to hyperglycemia (translocational hyponatremia)
Question 1530Question →

A 22-year-old man comes to the clinic due to worsening bilateral lower extremity swelling over the past 3 weeks. He reports that his urine has become very frothy. He has no other chronic medical conditions but has experienced recurrent, self-limited episodes of fever and severe, diffuse abdominal pain since childhood. During these episodes, which occur 2 to 3 times a year and last 48 to 72 hours, he also occasionally develops right ankle swelling and pain. He recently moved to the United States from Turkey and has not had a primary care provider in several years. His parents are first cousins. Vital signs are within normal limits. Physical examination reveals moderate ascites and 3+ pitting edema up to the knees.

Laboratory results are as follows:

TestResult
Hemoglobin11.2 g/dL
Leukocyte count8,400/mm³
Serum creatinine1.5 mg/dL
Serum albumin2.2 g/dL
Urinalysis4+ protein, no red blood cells
24-hour urine protein7.2 g

A renal biopsy demonstrates amorphous deposits in the mesangium and capillary walls. When stained with Congo red and viewed under polarized light, the deposits exhibit apple-green birefringence. Long-term adherence to which of the following medications would have most effectively prevented this patient's current renal complication?

Show answer & explanation

Answer: Colchicine

Answer

Colchicine
This patient's clinical presentation is highly characteristic of Familial Mediterranean Fever (FMF), an autosomal recessive autoinflammatory disorder primarily affecting populations of Mediterranean origin (e.g., Turkish, Armenian, Sephardic Jewish, Arab). It is caused by mutations in the MEFV gene, which encodes pyrin, leading to unregulated inflammasome activation and excessive interleukin-1 (IL-1) production. Clinically, patients experience recurrent, self-limited episodes (typically lasting 1 to 3 days) of fever, serositis (most commonly peritonitis presenting as severe abdominal pain, or pleuritis), and arthritis (often monoarticular, affecting the lower extremities).

The most severe complication of FMF is secondary (AA) amyloidosis, resulting from the chronic hepatic overproduction of the acute-phase reactant serum amyloid A (SAA). Amyloid deposits in the kidney typically manifest as nephrotic syndrome (massive proteinuria, hypoalbuminemia, and severe edema), as seen in this patient. The diagnosis is confirmed by renal biopsy demonstrating amorphous deposits that show characteristic apple-green birefringence under polarized light after Congo red staining.

Continuous, lifelong therapy with colchicine is the standard of care for FMF. Colchicine binds to tubulin, inhibiting microtubule polymerization and thereby disrupting neutrophil chemotaxis and degranulation. It is highly effective not only in decreasing the frequency and severity of acute FMF attacks but also in completely preventing the development of AA amyloidosis.

Step-by-Step Solution

1
Analyze the patient's clinical history and demographics.
Recurrent short-lived fevers, serositis (abdominal pain), and monoarthritis in a patient of Mediterranean descent with consanguineous parents.
These are the classic hallmark features of Familial Mediterranean Fever (FMF).
2
Evaluate the current presentation and laboratory findings.
Nephrotic range proteinuria (7.2 g/day), hypoalbuminemia, edema, and a renal biopsy showing Congo red-positive deposits with apple-green birefringence.
This confirms a diagnosis of secondary (AA) amyloidosis presenting as nephrotic syndrome, which is the most severe long-term complication of untreated FMF.
3
Determine the appropriate prophylactic therapy for the underlying condition.
Colchicine is identified as the required lifelong medication.
Colchicine impairs neutrophil function and is uniquely effective in preventing both the acute inflammatory flares of FMF and the tissue deposition of serum amyloid A (SAA) protein.

Key Concept

Secondary (AA) amyloidosis is a major complication of untreated Familial Mediterranean Fever (FMF); lifelong prophylaxis with colchicine prevents both acute inflammatory attacks and amyloid deposition.
Question 1531Question →

An 68-year-old woman is brought to the emergency department by her daughter due to progressive confusion, agitation, and nausea over the past 24 hours. The daughter notes that the patient has had a mild upper respiratory illness for the last few days and has been taking an over-the-counter remedy frequently. The patient has a medical history of severe osteoarthritis and hypertension. Current home medications include lisinopril and multiple daily doses of an over-the-counter pain reliever.

Temperature is 37.8°C (100.0°F), blood pressure is 110/65 mm Hg, pulse is 114/min, and respirations are 28/min. Pulse oximetry shows 98% on ambient air. Physical examination reveals a diaphoretic, agitated woman who is oriented only to person. She occasionally complains of a "ringing" sound in her ears. The lungs are clear to auscultation bilaterally. Cardiac examination shows tachycardia with a regular rhythm. There is mild, diffuse epigastric tenderness.

Laboratory studies show the following:

Serum chemistry:
Sodium: 140 mEq/L
Potassium: 3.6 mEq/L
Chloride: 104 mEq/L
Bicarbonate: 14 mEq/L
Blood urea nitrogen: 24 mg/dL
Creatinine: 1.3 mg/dL
Glucose: 112 mg/dL

Complete blood count:
Leukocyte count: 14,500/mm³

Arterial blood gas analysis (room air):
pH: 7.42
PaCO2: 21 mm Hg
PaO2: 96 mm Hg

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravenous sodium bicarbonate

Answer

The most appropriate next step is the administration of intravenous sodium bicarbonate to alkalinize the serum and urine.
The patient's presentation is highly characteristic of acute salicylate (aspirin) toxicity. Key clinical features include tinnitus (the "ringing" sound), hyperventilation (tachypnea), hyperthermia, and agitation. The laboratory results reveal a classic mixed acid-base disorder: a primary respiratory alkalosis and a primary high anion gap metabolic acidosis.

The anion gap is elevated: AG=Na+−(Cl−+HCO3−)=140−(104+14)=22AG = Na^+ - (Cl^- + HCO_3^-) = 140 - (104 + 14) = 22.
For a primary metabolic acidosis with a bicarbonate of 1414 mEq/L, Winter's formula predicts respiratory compensation: Expected PaCO2=(1.5×14)+8=29±2Expected\ PaCO_2 = (1.5 \times 14) + 8 = 29 \pm 2 mm Hg.
Because the patient's actual PaCO2PaCO_2 (2121 mm Hg) is significantly lower than the expected range (27−3127-31 mm Hg), a concurrent primary respiratory alkalosis is present. This occurs because salicylates directly stimulate the medullary respiratory center.

The cornerstone of management for moderate-to-severe salicylate toxicity is intravenous sodium bicarbonate. This therapy has a dual purpose: 1) Serum alkalinization keeps the weak acid (salicylate) in its ionized, deprotonated state, preventing it from crossing the blood-brain barrier into the central nervous system. 2) Urine alkalinization traps the ionized salicylate in the renal tubules, profoundly enhancing its excretion.

Step-by-Step Solution

1
Interpret the basic metabolic panel and arterial blood gas results.
Identification of a high anion gap (AG=140−(104+14)=22AG = 140 - (104 + 14) = 22) metabolic acidosis. Using Winter's formula (Expected PaCO2=1.5×14+8=29±2Expected\ PaCO_2 = 1.5 \times 14 + 8 = 29 \pm 2), the actual PaCO2PaCO_2 of 2121 mm Hg is significantly lower than expected, confirming a concurrent primary respiratory alkalosis.
To accurately characterize the underlying pathophysiology of the patient's acute systemic disturbance.
2
Synthesize the laboratory findings with the clinical presentation.
Diagnosis of acute salicylate (aspirin) toxicity, supported by the classic acid-base disturbance, tinnitus, tachypnea, fever, and recent heavy use of an over-the-counter pain remedy for osteoarthritis.
To establish a definitive diagnosis before initiating potentially dangerous therapies.
3
Determine the optimal acute therapeutic intervention.
Selection of intravenous sodium bicarbonate infusion.
Sodium bicarbonate alkalinizes the blood (trapping salicylate in the ionized form so it cannot cross the blood-brain barrier) and alkalinizes the urine (dramatically increasing renal excretion of the toxin).

Key Concept

Salicylate toxicity classically presents with tinnitus, tachypnea, and a mixed primary respiratory alkalosis and high anion gap metabolic acidosis. Management centers on serum and urine alkalinization with intravenous sodium bicarbonate.
Question 1532Question →

A 72-year-old man is brought to the emergency department by his family due to confusion and severe weakness. He has a history of severe chronic obstructive pulmonary disease (COPD) and heart failure with preserved ejection fraction. For the past three days, he has experienced a worsening fever, productive cough, and profuse, intractable vomiting, leaving him unable to tolerate oral intake. His home medications include furosemide, lisinopril, and inhaled tiotropium.

On presentation, his temperature is 38.6°C (101.5°F), blood pressure is 82/50 mm Hg, pulse is 118/min, and respiratory rate is 26/min. Physical examination reveals lethargy, dry mucous membranes, and delayed capillary refill. Chest auscultation reveals diffuse wheezing and bilateral coarse crackles.

Laboratory studies show:

ParameterValue
Sodium140140 mEq/L
Potassium2.82.8 mEq/L
Chloride8282 mEq/L
Bicarbonate1818 mEq/L
Blood urea nitrogen6868 mg/dL
Creatinine3.43.4 mg/dL (baseline 1.11.1)
Lactate8.58.5 mmol/L

Arterial blood gas on room air:

ParameterValue
pH7.127.12
pCO2_25858 mm Hg
pO2_25454 mm Hg

Based on the laboratory findings, which of the following combinations best describes this patient's current acid-base disturbances?

Show answer & explanation

Answer: High anion gap metabolic acidosis, metabolic alkalosis, and respiratory acidosis

Answer

The patient has a triple acid-base disorder consisting of a high anion gap metabolic acidosis, a metabolic alkalosis, and a respiratory acidosis.
This patient presents with a highly complex clinical picture resulting in a triple acid-base disorder. First, calculating the anion gap yields 140−(82+18)=40140 - (82 + 18) = 40. An elevated gap (>12> 12) confirms a High Anion Gap Metabolic Acidosis (HAGMA), which correlates with his severe lactic acidosis (8.58.5 mmol/L) and uremia from acute kidney injury. Second, to determine if another metabolic process is present, the delta gap is calculated: ΔAG=40−12=28\Delta AG = 40 - 12 = 28. Adding this to the measured bicarbonate gives a 'corrected' bicarbonate of 18+28=4618 + 28 = 46 mEq/L. Because this is much higher than the normal 2424 mEq/L, there is a concurrent Metabolic Alkalosis, which is clinically consistent with his history of intractable vomiting and furosemide use (evidenced by severe hypochloremia and hypokalemia). Finally, Winter's formula (1.5×18+8=351.5 \times 18 + 8 = 35) dictates that the expected pCO2pCO_2 should be between 3333 and 3737 mm Hg. The patient's actual pCO2pCO_2 is 5858 mm Hg, establishing an independent Respiratory Acidosis driven by a severe COPD exacerbation and impending respiratory failure.

Step-by-Step Solution

1
Calculate the Anion Gap (AG).
AG=Na+−(Cl−+HCO3−)=140−(82+18)=40AG = Na^+ - (Cl^- + HCO_3^-) = 140 - (82 + 18) = 40.
An AG>12AG > 12 establishes the presence of a High Anion Gap Metabolic Acidosis (HAGMA), driven here by lactic acidosis and acute kidney injury.
2
Calculate the Delta Gap and Corrected Bicarbonate to check for a concurrent metabolic disorder.
ΔAG=40−12=28\Delta AG = 40 - 12 = 28. Corrected HCO3−=MeasuredHCO3−+ΔAG=18+28=46HCO_3^- = Measured HCO_3^- + \Delta AG = 18 + 28 = 46 mEq/L.
Because the corrected bicarbonate (4646 mEq/L) is significantly greater than the normal value of 2424 mEq/L, a concurrent primary Metabolic Alkalosis is present, caused by severe vomiting and furosemide use.
3
Calculate the expected pCO2pCO_2 using Winter's formula to evaluate respiratory compensation.
Expected pCO2=(1.5×18)+8±2=35±2pCO_2 = (1.5 \times 18) + 8 \pm 2 = 35 \pm 2 mm Hg.
To determine if the respiratory system is appropriately compensating for the measured bicarbonate level of 1818 mEq/L.
4
Compare the expected pCO2pCO_2 with the measured pCO2pCO_2.
Measured pCO2pCO_2 (5858 mm Hg) > Expected pCO2pCO_2 (33−3733-37 mm Hg).
Since the actual pCO2pCO_2 is higher than expected, there is a concurrent primary Respiratory Acidosis due to the patient's COPD exacerbation and respiratory fatigue.

Key Concept

Interpretation of mixed (triple) acid-base disorders requires sequential evaluation: Anion Gap, Delta-Delta calculation, and Winter's formula.

Alternative Method

Instead of the Delta Gap method, you can use the Delta Ratio (ΔAG/ΔHCO3−\Delta AG / \Delta HCO_3^-). ΔAG=40−12=28\Delta AG = 40 - 12 = 28. ΔHCO3−=24−18=6\Delta HCO_3^- = 24 - 18 = 6. The Delta Ratio is 28/6≈4.628 / 6 \approx 4.6. A Delta Ratio >2.0> 2.0 strongly indicates a concurrent metabolic alkalosis.
Estimated Time:2m 0s
Question 1533Question →

A 42-year-old man is brought to the emergency department by his wife due to fever, severe headache, and confusion for the past 24 hours. His temperature is 39.2°C (102.6°F), blood pressure is 110/70 mm Hg, and pulse is 112/min. Physical examination reveals nuchal rigidity and lethargy. He withdraws all four extremities to pain but does not follow commands. There is no papilledema, but his altered mental status raises concern for increased intracranial pressure.

Arrange the following steps in the most appropriate sequence for the management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately followed by empiric antibiotics and dexamethasone. Then, obtain a head CT, perform a lumbar puncture, and finally tailor the antimicrobial therapy based on culture results.
In cases of suspected bacterial meningitis with high-risk features (e.g., altered mental status, new-onset seizure, immunocompromised state, focal neurologic deficit, papilledema), a head CT must precede a lumbar puncture to rule out mass effect. However, life-saving antibiotics must not be delayed during this diagnostic workup. Therefore, the correct sequence is: draw blood cultures, administer empiric antibiotics and dexamethasone, obtain a head CT, perform a lumbar puncture, and then narrow antibiotics based on subsequent culture results.

Step-by-Step Solution

1
Identify the need for neuroimaging prior to a lumbar puncture.
The patient has signs of bacterial meningitis along with altered mental status (lethargy, not following commands), which is a strict criterion for a head CT before a lumbar puncture.
To prevent brain herniation during the lumbar puncture due to potential mass effect.
2
Determine the priority of acute interventions.
Blood cultures must be drawn first, followed immediately by empiric antibiotics and dexamethasone.
Antibiotics should never be delayed for imaging in suspected bacterial meningitis, as any delay in appropriate treatment significantly increases mortality.
3
Sequence the remaining diagnostic steps.
A non-contrast head CT is performed, followed safely by the lumbar puncture.
The CT scan ensures it is safe to proceed with cerebrospinal fluid sampling.
4
Plan for definitive, ongoing care.
The final step is to adjust the antibiotic regimen based on culture data.
Targeted therapy supports antibiotic stewardship, reducing resistance and minimizing adverse drug effects once the exact pathogen is identified.

Key Concept

Algorithmic management of suspected acute bacterial meningitis with indications for head imaging prior to lumbar puncture.
Question 1534Question →

A 3838-year-old woman comes to the clinic due to progressive fatigue, weight gain, and cold intolerance over the past 44 months. She also reports that she has not had a menstrual period for the past 55 months. She takes no medications and her past medical history is unremarkable. Her vital signs include a temperature of 36.1∘36.1^\circ C (97.0∘97.0^\circ F), blood pressure of 105/65105/65 mmHg, and a pulse of 5656/min. Physical examination reveals dry skin, facial puffiness, and delayed relaxation of the deep tendon reflexes. A urine pregnancy test is negative.

Laboratory results show:
Thyroid-stimulating hormone (TSH): 0.6μ0.6 \mu U/mL (Normal: 0.4−4.2μ0.4-4.2 \mu U/mL)
Free thyroxine (T4): 0.40.4 ng/dL (Normal: 0.8−2.80.8-2.8 ng/dL)

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Central hypothyroidism

Answer

Central hypothyroidism
The correct answer is central hypothyroidism. This patient presents with overt clinical signs of hypothyroidism, which is confirmed by her low free T4 level. In a normally functioning hypothalamic-pituitary-thyroid axis, a low free T4 should trigger an increase in TSH production due to the loss of negative feedback (primary hypothyroidism). However, this patient's TSH is inappropriately normal (0.6μ0.6 \mu U/mL). This lack of a robust TSH response points directly to a failure at the level of the pituitary gland or hypothalamus (central hypothyroidism). Her concurrent secondary amenorrhea further supports a broader pituitary dysfunction, such as a pituitary adenoma.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation.
The patient exhibits classic symptoms of hypothyroidism (fatigue, weight gain, cold intolerance, bradycardia, delayed reflexes) along with secondary amenorrhea.
To establish the clinical syndrome before interpreting the laboratory values.
2
Analyze the thyroid function tests.
The free T4 is abnormally low (0.40.4 ng/dL), which biochemically confirms the clinical suspicion of hypothyroidism.
Free T4 determines whether the patient is truly hypothyroid.
3
Assess the TSH response to the low free T4 level.
The TSH is 0.6μ0.6 \mu U/mL, which is inappropriately normal (not elevated) in the setting of a low free T4.
The TSH level differentiates between primary (thyroid gland) and central (pituitary or hypothalamus) causes of hypothyroidism.

Key Concept

Central hypothyroidism is diagnosed when a low free T4 is accompanied by an inappropriately normal or low TSH.
Question 1535Question →

A 3131-year-old man is evaluated in the emergency department for a 11-week history of worsening right upper quadrant abdominal pain and abdominal swelling. He also reports profound generalized fatigue and notes that his urine is dark reddish-brown in the morning, which clears as the day progresses. His temperature is 37.3∘C37.3^\circ\text{C} (99.1∘F99.1^\circ\text{F}), blood pressure is 132/84 mmHg132/84\text{ mmHg}, and pulse is 98/min98/\text{min}. Physical examination reveals mild scleral icterus and a tender, distended abdomen with shifting dullness. Hepatomegaly is appreciated, but there is no guarding or rebound tenderness.

Laboratory studies show:

TestResult
Hemoglobin8.4 g/dL8.4\text{ g/dL}
Leukocytes3,200/mm33,200/\text{mm}^3
Platelets105,000/mm3105,000/\text{mm}^3
Reticulocytes8%8\%
Total bilirubin3.8 mg/dL3.8\text{ mg/dL}
Indirect bilirubin3.1 mg/dL3.1\text{ mg/dL}
Lactate dehydrogenase2,100 U/L2,100\text{ U/L}
Haptoglobin<10 mg/dL<10\text{ mg/dL}
Aspartate aminotransferase (AST)85 U/L85\text{ U/L}
Alanine aminotransferase (ALT)92 U/L92\text{ U/L}

Doppler ultrasonography of the abdomen demonstrates ascites and an absence of blood flow in the hepatic veins.

Which of the following is the most likely underlying mechanism of this patient's condition?

Show answer & explanation

Answer: Absence of glycosylphosphatidylinositol-anchored proteins on cell surfaces

Answer

The correct answer is the absence of glycosylphosphatidylinositol-anchored proteins on cell surfaces, which describes the pathophysiology of Paroxysmal Nocturnal Hemoglobinuria (PNH).
The correct answer describes the pathophysiology of Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is an acquired clonal hematopoietic stem cell disorder characterized by a mutation in the PIGA gene. This mutation leads to an inability to synthesize glycosylphosphatidylinositol (GPI) anchors, which are required to attach various proteins to cell membranes. Crucially, the absence of GPI-anchored proteins includes the complement regulatory proteins CD55 (decay-accelerating factor) and CD59 (MAC-inhibitory protein). Without these inhibitors, red blood cells are highly susceptible to complement-mediated intravascular hemolysis, especially at night when mild respiratory acidosis naturally occurs (leading to the classic 'dark morning urine'). PNH classically presents with a triad of intravascular hemolysis, pancytopenia (due to bone marrow suppression), and a hypercoagulable state. Venous thrombosis in atypical locations, such as the hepatic veins (Budd-Chiari syndrome), portal, or cerebral veins, is a hallmark of the disease and a leading cause of mortality.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has a classic triad of intravascular hemolysis (high LDH, low haptoglobin, dark morning urine), pancytopenia (low hemoglobin, leukocytes, and platelets), and venous thrombosis (Budd-Chiari syndrome).
To identify the defining syndrome presented in the vignette.
2
Evaluate the etiology of Budd-Chiari syndrome in the context of the patient's cell counts.
While myeloproliferative neoplasms (like Polycythemia Vera) commonly cause Budd-Chiari syndrome, they present with elevated cell counts. This patient has pancytopenia, pointing toward bone marrow failure syndromes.
To differentiate between the major hematologic causes of hepatic vein thrombosis.
3
Connect the combination of intravascular hemolysis, pancytopenia, and atypical venous thrombosis to a single diagnosis.
This specific triad is the hallmark of Paroxysmal Nocturnal Hemoglobinuria (PNH).
To arrive at the definitive diagnosis before reviewing the answer choices.
4
Identify the underlying molecular mechanism of PNH.
PNH is caused by an acquired mutation in the PIGA gene, leading to a deficiency of glycosylphosphatidylinositol (GPI) anchors. This results in the absence of GPI-anchored complement inhibitors (CD55 and CD59) on the cell surface, making erythrocytes susceptible to complement-mediated destruction.
To match the clinical diagnosis with the correct pathophysiological mechanism described in the options.

Key Concept

Paroxysmal nocturnal hemoglobinuria (PNH) presents with the classic triad of intravascular hemolysis, pancytopenia, and venous thrombosis (often in atypical locations such as hepatic or cerebral veins), caused by a deficiency of GPI-anchored complement inhibitors (CD55, CD59) on cell surfaces.
Question 1536Question →

A 3939-year-old man comes to the clinic reporting a 66-month history of profound fatigue, decreased libido, and a 5-kg5\text{-kg} (11-lb11\text{-lb}) weight gain. He has no prior medical history but was involved in a severe motorcycle collision 1818 months ago, sustaining a basilar skull fracture that required a 33-week intensive care unit stay. His blood pressure is 100/65 mmHg100/65\text{ mmHg} and heart rate is 56/min56\text{/min}. Physical examination shows pale, dry skin, loss of axillary and pubic hair, and a delayed relaxation phase of the deep tendon reflexes. Laboratory results are as follows:

TestResultReference Range
Serum sodium133 mEq/L133 \text{ mEq/L}136−145 mEq/L136 - 145 \text{ mEq/L}
Serum potassium4.0 mEq/L4.0 \text{ mEq/L}3.5−5.0 mEq/L3.5 - 5.0 \text{ mEq/L}
Thyroid-stimulating hormone (TSH)2.1 \muU/mL2.1 \text{ \mu U/mL}0.4−4.0 \muU/mL0.4 - 4.0 \text{ \mu U/mL}
Free T40.5 ng/dL0.5 \text{ ng/dL}0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL}

Which of the following is the most appropriate next step in patient care?

Show answer & explanation

Answer: Measurement of 8 AM serum cortisol

Answer

Measurement of 8 AM serum cortisol is the most appropriate next step to rule out concurrent central adrenal insufficiency before initiating thyroid replacement.
The correct next step is evaluating the adrenal axis with an 8 AM serum cortisol. This patient's laboratory profile (low Free T4, normal TSH) is diagnostic of central hypothyroidism, likely a delayed consequence of traumatic brain injury (TBI-induced hypopituitarism). Because TBI often causes multiple anterior pituitary hormone deficiencies, he is at high risk for concurrent central adrenal insufficiency. Thyroid hormone increases hepatic clearance of cortisol. Therefore, administering levothyroxine to a patient with unrecognized adrenal insufficiency can precipitate an acute, life-threatening adrenal crisis. Glucocorticoid deficiency must always be ruled out or treated prior to initiating thyroid hormone replacement in panhypopituitarism.

Step-by-Step Solution

1
Interpret the laboratory findings in the context of the patient's history.
The patient has a low Free T4 (0.5 ng/dL0.5 \text{ ng/dL}) but a TSH that is inappropriately within the normal reference range (2.1 \muU/mL2.1 \text{ \mu U/mL}), rather than elevated.
This specific pattern points to a central (pituitary or hypothalamic) failure to produce TSH, rather than primary failure of the thyroid gland itself.
2
Correlate the biochemical pattern with the clinical presentation.
The history of severe traumatic brain injury, combined with signs of hypogonadism (loss of body hair, decreased libido) and mild hyponatremia, suggests panhypopituitarism.
Traumatic brain injury can cause shear stress on the pituitary stalk or direct ischemic injury to the gland, leading to multiple anterior pituitary hormone deficiencies.
3
Determine the necessary safety step before managing the hypothyroidism.
The adrenal axis must be evaluated (e.g., via 8 AM serum cortisol or a cosyntropin stimulation test) before giving thyroid hormone.
Thyroid hormone replacement increases basal metabolic rate and hepatic clearance of cortisol. If a patient has undiagnosed central adrenal insufficiency, administering levothyroxine first can rapidly deplete remaining cortisol stores and precipitate an acute adrenal crisis.

Key Concept

In patients with suspected central hypothyroidism (indicated by low Free T4 with inappropriately normal or low TSH), concurrent central adrenal insufficiency must be ruled out with an 8 AM cortisol or ACTH stimulation test before initiating levothyroxine therapy to avoid precipitating an adrenal crisis.
Estimated Time:2m 0s
Question 1537Question →

A 58-year-old man is evaluated in the intensive care unit for ongoing antibiotic management. He was admitted 10 days ago following a severe traumatic brain injury that required mechanical ventilation. Five days ago, he developed a new fever of 38.9°C (102.0°F), increased purulent endotracheal secretions, and worsening oxygenation. A portable chest radiograph revealed a new right lower lobe infiltrate. He was empirically started on intravenous vancomycin and piperacillin-tazobactam for presumed ventilator-associated pneumonia. Today, the patient's temperature is 37.2°C (99.0°F), and his oxygen requirements have steadily decreased. A bronchoalveolar lavage culture obtained 48 hours ago has finalized, growing >10510^5 CFU/mL of methicillin-susceptible *Staphylococcus aureus* (MSSA). Blood cultures drawn at the time of the fever remain sterile. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue vancomycin and piperacillin-tazobactam, and initiate intravenous cefazolin

Answer

Discontinue vancomycin and piperacillin-tazobactam, and initiate intravenous cefazolin
The correct approach for a patient with ventilator-associated pneumonia caused by methicillin-susceptible Staphylococcus aureus (MSSA) is to de-escalate from broad-spectrum empiric therapy to a targeted, narrow-spectrum beta-lactam agent. Intravenous cefazolin, nafcillin, or oxacillin are the drugs of choice for severe MSSA infections. They provide superior bactericidal activity, faster clinical resolution, and lower mortality compared to vancomycin for MSSA, while minimizing unnecessary broad-spectrum antimicrobial exposure.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and microbiology results.
The patient is improving, and the bronchoalveolar lavage culture has confirmed a single pathogen: methicillin-susceptible Staphylococcus aureus (MSSA).
Identifying the specific organism and its susceptibility profile allows for the transition from empiric to definitive targeted therapy.
2
Determine the optimal definitive antibiotic for MSSA pneumonia.
Anti-staphylococcal beta-lactams (e.g., cefazolin, nafcillin, oxacillin) are the most effective agents for MSSA.
Beta-lactams provide superior bactericidal activity against MSSA compared to vancomycin, leading to improved clearance and better clinical outcomes.
3
Apply antimicrobial stewardship principles to the current regimen.
The empiric regimen of vancomycin and piperacillin-tazobactam must be stopped and replaced with targeted cefazolin therapy.
Vancomycin is inferior for MSSA, and piperacillin-tazobactam is unnecessarily broad-spectrum, increasing the risk for multi-drug resistant superinfections and unnecessary toxicity.

Key Concept

Antimicrobial de-escalation for methicillin-susceptible Staphylococcus aureus (MSSA) infections
Question 1538Question →

A 34-year-old woman comes to the outpatient clinic due to profound fatigue, weight gain, cold intolerance, and constipation that have progressively worsened over the last 6 months. She also notes that her menstrual cycles, which were previously regular, have been absent for the past 8 months. She takes no medications and has no other medical conditions. Her blood pressure is 98/60 mm Hg and pulse is 54/min. Physical examination demonstrates dry skin, brittle hair, and delayed relaxation phase of the deep tendon reflexes. Visual fields are full to confrontation.

Laboratory results are as follows:

Laboratory TestResultReference Range
Thyroid-stimulating hormone (TSH)1.2 mU/L1.2 \text{ mU/L}0.5−5.0 mU/L0.5 - 5.0 \text{ mU/L}
Free thyroxine (T4)0.5 ng/dL0.5 \text{ ng/dL}0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL}

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measurement of early morning serum cortisol

Answer

Measurement of early morning serum cortisol
The correct answer is the measurement of early morning serum cortisol. This patient presents with classic signs of hypothyroidism (fatigue, weight gain, cold intolerance, delayed deep tendon reflexes), but her laboratory tests reveal a low free T4 with an inappropriately normal TSH. This discordant pattern indicates central (secondary) hypothyroidism rather than primary thyroid gland failure. Furthermore, the presence of secondary amenorrhea strongly points toward a broader diagnosis of panhypopituitarism, possibly caused by a pituitary adenoma or another sellar lesion. When central hypothyroidism is identified, it is imperative to evaluate the hypothalamic-pituitary-adrenal axis before initiating thyroid hormone replacement. Levothyroxine increases the basal metabolic rate and accelerates the hepatic clearance of cortisol. If a patient has coexisting central adrenal insufficiency, starting levothyroxine without concurrent glucocorticoid coverage can rapidly deplete any remaining cortisol reserves and precipitate a life-threatening acute adrenal crisis.

Step-by-Step Solution

1
Interpret the thyroid function tests in the context of the patient's symptoms.
The patient has clinical hypothyroidism with a low free T4 and an inappropriately normal TSH, establishing a diagnosis of central (secondary) hypothyroidism.
Accurate interpretation of the pituitary-thyroid axis is required to localize the pathology to the pituitary or hypothalamus.
2
Identify clues indicating broader pituitary dysfunction.
The presence of secondary amenorrhea alongside central hypothyroidism suggests panhypopituitarism.
Pituitary lesions often affect multiple hormone axes simultaneously, necessitating a broader evaluation.
3
Determine the necessary safety steps before initiating treatment.
The adrenal axis must be evaluated with an early morning serum cortisol level.
Starting levothyroxine increases cortisol clearance; if underlying central adrenal insufficiency is present and untreated, this can precipitate a fatal adrenal crisis.

Key Concept

Patients diagnosed with central hypothyroidism must be evaluated for concurrent central adrenal insufficiency before initiating levothyroxine therapy to avoid precipitating an acute adrenal crisis.
Question 1539Question →

A 34-year-old woman is evaluated for progressive weight gain, profound fatigue, and easy bruising over the past 8 months. Physical examination reveals facial plethora, marked central adiposity, supraclavicular fat pads, and wide violaceous abdominal striae. Her blood pressure is 158/96 mmHg. She takes no medications and has not used any exogenous glucocorticoids. Endogenous Cushing syndrome is suspected.

Arrange the following interventions in the most appropriate chronological sequence for the diagnostic workup and definitive management of this patient. Assume that the patient is ultimately proven to have Cushing disease caused by a biochemically active but radiologically equivocal (4-mm) pituitary microadenoma.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order for the diagnostic workup and management of Cushing disease is: (1) Measurement of 24-hour urinary free cortisol to establish hypercortisolism, (2) Measurement of early morning plasma ACTH to determine ACTH dependency, (3) MRI of the pituitary gland to localize the tumor, (4) Inferior petrosal sinus sampling to definitively confirm the central source of a microadenoma, and (5) Transsphenoidal adenomectomy as the definitive surgical treatment.
The evaluation of Cushing syndrome requires a rigid, stepwise algorithmic approach to prevent misdiagnosis. First, hypercortisolism must be proven biochemically (24-hour urine free cortisol). Second, the mechanism must be identified as ACTH-dependent or independent (plasma ACTH). Third, the source must be localized with imaging (pituitary MRI). Fourth, because the MRI finding in this scenario is less than 6 mm, it is considered radiologically equivocal due to the high population prevalence of pituitary incidentalomas; therefore, invasive confirmation with IPSS is mandatory. Finally, once IPSS confirms the pituitary as the source of ACTH, transsphenoidal adenomectomy is performed.

Step-by-Step Solution

1
Measurement of 24-hour urinary free cortisol
Confirms the presence of pathological hypercortisolism.
Before any localizing tests, the biochemical presence of hypercortisolism must be definitively established to rule out physiologic variants or normal fluctuations.
2
Measurement of early morning plasma ACTH
Differentiates ACTH-independent from ACTH-dependent Cushing syndrome.
This determines whether the source of excess cortisol is primary adrenal (low ACTH) or driven by a central/ectopic source (high/normal ACTH).
3
Magnetic resonance imaging (MRI) of the pituitary gland
Attempts to visualize a pituitary adenoma.
Once an ACTH-dependent etiology is confirmed, the pituitary is the most likely source, making MRI the appropriate first-line imaging study.
4
Inferior petrosal sinus sampling (IPSS)
Confirms a central-to-peripheral ACTH gradient.
Because pituitary incidentalomas are found in up to 10% of healthy individuals, a lesion less than 6 mm is considered equivocal. IPSS is required to rule out ectopic ACTH secretion before proceeding to surgery.
5
Transsphenoidal adenomectomy
Resection of the pituitary adenoma and resolution of hypercortisolism.
This is the definitive therapeutic intervention once the pituitary source is unequivocally confirmed.

Key Concept

Algorithm for the step-wise biochemical diagnosis, radiological localization, and surgical management of endogenous Cushing syndrome.
Question 1540Question →

A 27-year-old woman is brought to the emergency department by her roommate due to persistent nausea, vomiting, and diffuse abdominal pain for the past 24 hours. She has a history of type 1 diabetes mellitus and reports that she ran out of her insulin prescription two days ago. On physical examination, she appears lethargic but is easily arousable. Her respiratory rate is 26/min26/\text{min} and breaths are deep and rapid.

Laboratory testing reveals the following:

Laboratory TestResult
Serum sodium136 mEq/L136 \text{ mEq/L}
Serum potassium5.1 mEq/L5.1 \text{ mEq/L}
Serum chloride98 mEq/L98 \text{ mEq/L}
Serum bicarbonate12 mEq/L12 \text{ mEq/L}
Arterial blood pH7.227.22
Arterial PaCO2\text{PaCO}_226 mm Hg26 \text{ mm Hg}

Which of the following most accurately describes this patient's primary acid-base disturbance?

Show answer & explanation

Answer: Elevated anion gap metabolic acidosis with adequate respiratory compensation

Answer

Elevated anion gap metabolic acidosis with adequate respiratory compensation
The patient's low pH (7.227.22) and low bicarbonate (12 mEq/L12 \text{ mEq/L}) demonstrate a metabolic acidosis. The anion gap is calculated as 136−(98+12)=26136 - (98 + 12) = 26, which signifies an elevated anion gap metabolic acidosis (consistent with diabetic ketoacidosis). Using Winter's formula, the expected compensatory PaCO2\text{PaCO}_2 is calculated as (1.5×12)+8=26±2 mm Hg(1.5 \times 12) + 8 = 26 \pm 2 \text{ mm Hg}. Since the patient's actual PaCO2\text{PaCO}_2 is 26 mm Hg26 \text{ mm Hg}, the respiratory compensation is entirely adequate, and there are no superimposed respiratory disturbances.

Step-by-Step Solution

1
Determine the primary disturbance by analyzing the pH and serum bicarbonate.
The pH is 7.227.22 (acidemia) and serum bicarbonate is 12 mEq/L12 \text{ mEq/L} (low), indicating a primary metabolic acidosis.
Identifying the initial direction of pH and primary buffering molecule changes establishes the core acid-base status.
2
Calculate the serum anion gap.
Anion Gap=Na+−(Cl−+HCO3−)=136−(98+12)=136−110=26\text{Anion Gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 136 - (98 + 12) = 136 - 110 = 26. A value of 2626 is greater than the normal range (8−128-12), confirming an elevated anion gap metabolic acidosis.
An elevated anion gap is characteristic of conditions producing unmeasured organic acids, such as diabetic ketoacidosis.
3
Apply Winter's formula to determine if respiratory compensation is appropriate.
Expected PaCO2=(1.5×HCO3−)+8±2\text{Expected PaCO}_2 = (1.5 \times \text{HCO}_3^-) + 8 \pm 2. Calculation: (1.5×12)+8=18+8=26(1.5 \times 12) + 8 = 18 + 8 = 26. The expected range is 2424 to 28 mm Hg28 \text{ mm Hg}.
Comparing the expected carbon dioxide level to the patient's measured PaCO2\text{PaCO}_2 (26 mm Hg26 \text{ mm Hg}) reveals if there is a secondary, superimposed respiratory disorder.
4
Interpret the final results.
The measured PaCO2\text{PaCO}_2 matches the expected value perfectly.
Because the measured value falls precisely within the calculated range, the patient has an elevated anion gap metabolic acidosis with adequate respiratory compensation, and no secondary acid-base disorder.

Key Concept

Identifying complex acid-base disorders requires calculating the anion gap to classify metabolic acidosis and applying Winter's formula to assess for appropriate respiratory compensation.
Estimated Time:1m 0s
PreviousPage 77 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 77 | Examkin